Characterization of human CD8 T cell responses in dengue virus-infected patients from India

Journal of Virology

Volumn 90, Issue 24, 2016, Pages 11259-11278

  Chandele, Anmol ^a   Sewatanon, Jaturong ^d,f   Gunisetty, Sivaram ^d   Singla, Mohit ^b   Onlamoon, Nattawat ^c   Akondy, Rama S ^d   Kissick, Haydn Thomas ^d,f   Nayak, Kaustuv ^a   Reddy, Elluri Seetharami ^a   Kalam, Haroon ^a   Kumar, Dhiraj ^a   Verma, Anil ^b   Panda, HareKrushna ^a   Wang, Siyu ^c   Angkasekwinai, Nasikarn ^f   Pattanapanyasat, Kovit ^c   Chokephaibulkit, Kulkanya ^f   Medigeshi, Guruprasad R ^e   Lodha, Rakesh ^b   Kabra, Sushil ^b   Ahmed, Rafi ^d   Murali Krishna, Kaja ^a,d   more..

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c MAHIDOL UNIVERSITY   (Thailand)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IONOMYCIN; T LYMPHOCYTE RECEPTOR; VIRAL PROTEIN; ANTIBODY; CD28 ANTIGEN; CD3 ANTIGEN; CD38 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NS3 PROTEIN, FLAVIVIRUS; PHORBOL 13 ACETATE 12 MYRISTATE; RNA HELICASE; SERINE PROTEINASE; TRANSCRIPTOME;

ADOLESCENT; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENGUE; DOWN REGULATION; EFFECTOR CELL; FEMALE; FEVER; HUMAN; HUMAN CELL; INDIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; THAILAND; TRANSCRIPTOMICS; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELLULAR IMMUNITY; DENGUE VIRUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFANT; METABOLISM; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; VIROLOGY;

ADOLESCENT; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD38; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; DENGUE VIRUS; FEMALE; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INDIA; INFANT; INTERFERON-GAMMA; IONOMYCIN; MALE; MEMBRANE GLYCOPROTEINS; PRIMARY CELL CULTURE; RECEPTORS, ANTIGEN, T-CELL; RNA HELICASES; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTOME; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85000995844     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01424-16     Document Type: Article

References (42)

1. Appanna R, Ponnampalavanar S, Lum Chai See L, Sekaran SD. 2010. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One 5:e13029. http://dx.doi.org/10.1371/journal.pone.0013029.
2. Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de Oliveira-Pinto LM. 2006. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz 101:437-449 http://dx.doi.org/10.1590/S0074-02762006000400016.
3. + T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 176:2817-2824 http://dx.doi.org/10.4049/jimmunol.176.5.2817.
4. + T lymphocyte expansion, proliferation and activation in dengue fever. PLoS Negl Trop Dis 9:e0003520. http://dx.doi.org /10.1371/journal.pntd.0003520.
5. Duangchinda T, Dejnirattisai W, Vasanawathana S, Limpitikul W, Tangthawornchaikul N, Malasit P, Mongkolsapaya J, Screaton G. 2010. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A 107:16922-16927. http://dx.doi.org /10.1073/pnas.1010867107.
6. + T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol 184:7281-7287. http://dx.doi.org/10.4049/jimmunol.0903262.
7. Falcon-Lezama JA, Ramos C, Zuniga J, Juarez-Palma L, Rangel-Flores H, Garcia-Trejo AR, Acunha-Alonzo V, Granados J, Vargas-Alarcon G. 2009 HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever. Acta Trop 112:193-197. http://dx.doi.org/10.1016 /j.actatropica.2009.07.025.
8. Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, Kurane I, Rothman AL, Ennis FA. 1999. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 180:1429-1435. http://dx.doi.org/10.1086 /315072.
9. Green S, Rothman A. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19:429-436. http: //dx.doi.org/10.1097/01.qco.0000244047.31135.fa.
10. Gubler DJ. 2006. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 277:3-16; discussion 16-22, 71-13, 251-253. http://dx.doi.org/10.1002/0470058005.ch2.
11. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8:S7-S16. http://dx.doi.org /10.1038/nrmicro2460.
12. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV. 2001. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184: 1369-1373. http://dx.doi.org/10.1086/324320.
13. + T cells to heterologous serotypes. J Immunol 175: 2676-2683. http://dx.doi.org/10.4049/jimmunol.175.4.2676.
14. Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, Vo DT, Ha MT, Vo VT, Cao TP, Tran VD, Oyama T, Morita K, Yasunami M, Hirayama K. 2008 Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLAA* 24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2:e304. http://dx.doi.org/10.1371/journal.pntd.0000304.
15. Weiskopf D, Sette A. 2014. T-cell immunity to infection with dengue virus in humans. Front Immunol 5:93. http://dx.doi.org/10.3389/fimmu.2014.00093.
16. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 168:5959-5965. http://dx.doi.org/10.4049/jimmunol.168.11.5959.
17. + T cell responses are associated with a memory PD-1+ phenotype. J Virol 90: 4771-4779. http://dx.doi.org/10.1128/JVI.02892-15.
18. + T cells. Proc Natl Acad Sci U S A 110:E2046-E2053. http://dx.doi.org/10.1073/pnas.1305227110.
19. World Health Organization. 2009. Dengue: Guidelines for diagnosis, treatment, prevention and control. World Health Organization, Geneva, Switzerland.
20. Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A, Kwissa M, Pulendran B, Wilson PC, Wittawatmongkol O, Yoksan S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Ahmed R. 2012. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol 86:2911-2918. http://dx.doi.org/10.1128/JVI.06075-11.
21. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. 2007. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251-3253. http://dx.doi.org/10.1093/bioinformatics/btm369.
22. Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, Yoksan S, Pattanapanyasat K, Chokephaibulkit K, Ahmed R, Pulendran B. 2014. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16:115-127. http://dx.doi.org/10.1016/j.chom.2014.06.001.
23. Sun P, Garcia J, Comach G, Vahey MT, Wang Z, Forshey BM, Morrison AC, Sierra G, Bazan I, Rocha C, Vilcarromero S, Blair PJ, Scott TW, Camacho DE, Ockenhouse CF, Halsey ES, Kochel TJ. 2013. Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity. PLoS Negl Trop Dis 7:e2298. http://dx.doi.org/10.1371/journal.pntd.0002298.
24. Nascimento EJ, Braga-Neto U, Calzavara-Silva CE, Gomes AL, Abath FG, Brito CA, Cordeiro MT, Silva AM, Magalhaes C, Andrade R, Gil LH, Marques ET, Jr. 2009. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS One 4:e7892. http://dx.doi.org/10.1371/journal.pone.0007892.
25. + T cells that provide the proliferative burst after PD-1 therapy. Nature 537:417-421. http://dx.doi.org/10.1038/nature19330.
26. + T cell response. J Immunol 183:7919-7930. http://dx.doi.org/10.4049 /jimmunol.0803903.
27. + T cells specific for EBV, cytomega-lovirus, and influenza virus are activated during primary HIV infection. J Immunol 173:2410-2418. http://dx.doi.org/10.4049/jimmunol.173.4.2410.
28. Singla M, Kar M, Sethi T, Kabra SK, Lodha R, Chandele A, Medigeshi GR. 2016. Immune response to dengue virus infection in pediatric patients in New Delhi, India-association of viremia, inflammatory mediators and monocytes with disease severity. PLoS Negl Trop Dis 10: e0004497. http://dx.doi.org/10.1371/journal.pntd.0004497.
29. Rivino L, Kumaran EA, Thein TL, Too CT, Gan VC, Hanson BJ, Wilder-Smith A, Bertoletti A, Gascoigne NR, Lye DC, Leo YS, Akbar AN, Kemeny DM, MacAry PA. 2015. Virus-specific T lymphocytes home to the skin during natural dengue infection. Sci Transl Med 7:278ra235. http://dx.doi.org/10.1126/scitranslmed.aaa0526.
30. Grant EJ, Quinones-Parra SM, Clemens EB, Kedzierska K. 2016. Human influenza viruses and CD8(+) T cell responses. Curr Opin Virol 16:132-142. http://dx.doi.org/10.1016/j.coviro.2016.01.016.
31. + T cell responses in blood and airways during episodes of common cold. J Immunol 181:5551-5559. http://dx.doi.org/10.4049/jimmunol.181.8.5551.
32. + T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722. http://dx.doi.org/10.1016/j.immuni.2008.02.020.
33. + T cells following live-attenuated chimeric West Nile virus vaccination. J Infect Dis 203:513-522. http://dx.doi.org/10.1093 /infdis/jiq074.
34. Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK. 2011. Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 85:10252-10260. http://dx.doi.org/10.1128/JVI.05548-11.
35. McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Stroher U, Damon I, Nichol ST, Spiropoulou CF, Ahmed R. 2015. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 112:4719-4724. http://dx.doi.org/10.1073/pnas.1502619112.
36. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512. http://dx.doi.org/10.1084/jem.191.9.1499.
37. + T cell activation during hyperacute HIV infection impact viral set point. Immunity 43:591-604. http://dx.doi.org/10.1016/j.immuni.2015.08.012.
38. Wherry EJ, Kurachi M. 2015. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15:486-499. http://dx.doi.org/10.1038 /nri3862.
39. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205-2213. http://dx.doi.org/10.1084/jem.188.12.2205.
40. Kim PS, Ahmed R. 2010. Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22:223-230. http://dx.doi.org/10.1016/j.coi.2010.02.005.
41. Pauken KE, Wherry EJ. 2015. Overcoming T cell exhaustion in infection and cancer. Trends Immunol 36:265-276. http://dx.doi.org/10.1016/j.it.2015.02.008.
42. John DV, Lin YS, Perng GC. 2015. Biomarkers of severe dengue disease-a review. J Biomed Sci 22:83. http://dx.doi.org/10.1186/s12929-015-0191-6.